Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Psychiatry/Psychology

Search Medical Condition
Please enter condition
Please choose location

Schizophrenia and Schizoaffective Disorders Clinical Trials

A listing of Schizophrenia and Schizoaffective Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (64) clinical trials

A phase III study to evaluate weight gain of ALKS3831 compared to olanzapine in adults with schizophrenia

Phase

A clinical research study evaluating an investigational medication for Its safety and effectiveness in the treatment of Schizophrenia. Eligibility Criteria: 18 years or older Diagnosed with schizophrenia Currently stable Other Details: Eligible participants will receive investigational medication as well as study related tests and procedures at no cost.

Outpatient study for an investigational medication for schizophrenia. Inclusionary Criteria: Males and females Between the ages of 18-70 Schizophrenia or Schizoaffective disorder Length of Study approx 2 month Total number of outpatient visits: 7

Phase N/A

An 8 week, placebo-controlled, double-blind, randomized, fixed-dose efficacy and safety study of asenapine in adolescent subjects with schizophrenia. Patient Inclustion Criteria: The subject is aged between 10 and 17 years, inclusive. The subject suffers from schizophrenia.

Phase

A randomized, double-blind, placebo-controlled, parallel-26 week, phase 3 study of 2 doses of an alpha-nicotinic acetylcholine receptor agonist (EVP-6124) or placebo as an adjunctive pro-cognitive treatment in schizophrenic subjects on chronic stable atypical antipsychotic therapy.

Phase
Phase N/A

Daniel Mamah, MD is conducting a research study to examine brain functional connectivity and network patterns in participants with schizophrenia or bipolar disorder. Participation includes 2 outpatient study visits that will last about 2 - 5 hours each. There will be an MRI scan and clinical assessment/interview. Possible risks and ...

Phase N/A

An adaptive, Phase IIB/III, double-blind, randomized, placebo-controlled, multi-center study of the safety and efficacy of study drug used for treatment of Schizophrenia in Adolescents

Phase N/A

The study will evaluate the antipsychotic efficacy of ITI-007 in a randomized, double-blind, parallel-group, placebo- and active-controlled, multi-center study in patients diagnosed with schizophrenia having an acute exacerbation of psychosis.

Phase

A Phase II, Randomized, Double-blind Study to Evaluate Efficacy, Safety, and Tolerablity of ALKS 3831 in Subjects with Schizophrenia with Alcohol Use Disorder

Phase